Testosterone replacement therapy (TRT) is one of the most commonly prescribed hormone treatments in men, with prescriptions quadrupling in the United States between 2001 and 2013. Yet an alarming number of men begin TRT without ever being told the most important side effect for those who want children: TRT reliably shuts down sperm production and can cause azoospermia — zero sperm — within three to six months. This makes TRT one of the most common reversible contributors to male factor infertility.
This is not a rare complication. It is the expected, predictable physiological consequence of exogenous testosterone. Understanding how it happens, how long it takes to reverse, and what alternatives exist could be the difference between conceiving naturally and needing IVF with testicular sperm extraction — or, in some cases, never regaining fertility at all.
The HPG Axis: How Testosterone and Sperm Production Are Linked
To understand how TRT disrupts fertility, you need to understand the hypothalamic-pituitary-gonadal (HPG) axis — the hormonal feedback loop that controls both testosterone production and sperm development.
Under normal circumstances:
- The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses
- GnRH signals the pituitary gland to release two hormones: FSH (follicle-stimulating hormone) and LH (luteinizing hormone)
- LH tells the Leydig cells in the testicles to produce testosterone
- FSH acts on Sertoli cells to support spermatogenesis (sperm production)
- Rising testosterone feeds back to the hypothalamus and pituitary to reduce GnRH, FSH, and LH — a negative feedback loop
When you take exogenous testosterone (in any form — injections, gels, pellets, patches), your blood testosterone rises sharply. The hypothalamus detects elevated testosterone and suppresses GnRH. With no GnRH pulse, the pituitary stops releasing LH and FSH. Without LH, Leydig cells stop making intratesticular testosterone. Without FSH, Sertoli cells can no longer support sperm development. The result: spermatogenesis shuts down.
This is a contraceptive mechanism so reliable that testosterone has been studied as a male contraceptive in WHO-funded clinical trials — with 98.6% effectiveness at suppressing sperm counts to azoospermic or severely oligospermic levels.
How Quickly Does TRT Cause Azoospermia?
The timeline varies by individual, dose, and TRT formulation, but the general pattern is:
| Timeframe on TRT | Expected Change |
|---|---|
| 2–4 weeks | LH and FSH begin to suppress |
| 6–8 weeks | Sperm concentration begins to fall |
| 3–6 months | Most men reach severe oligospermia (<5 million/mL) |
| 4–6 months | Azoospermia in 40–65% of men |
| >12 months | Azoospermia in >90% of men on supraphysiological doses |
Coviello et al. (Journal of Clinical Endocrinology and Metabolism, 2005) demonstrated in a controlled study that testosterone enanthate at standard replacement doses (200 mg every 2 weeks) suppressed sperm concentrations to <1 million/mL in the majority of subjects within 8–16 weeks, with most reaching azoospermia by month 4.
Higher doses — common in testosterone used for bodybuilding or performance enhancement — suppress more rapidly and more completely.
Recovery After Stopping TRT
The most common question reproductive urologists hear: "If I stop TRT, how long before my sperm come back?"
The honest answer: most men recover, but recovery is slow, incomplete in some, and never guaranteed.
Typical Recovery Timeline
| Time After Stopping TRT | Typical Milestone |
|---|---|
| 1–3 months | LH and FSH begin to rise |
| 3–6 months | Sperm begin to reappear in ejaculate |
| 6–12 months | Sperm count reaches moderate levels |
| 12–24 months | Most men approach baseline (pre-TRT) sperm parameters |
| >24 months | Remaining recovery plateau; some men do not fully recover |
A meta-analysis by Liu et al. found that among men who had been on testosterone-based contraceptive regimens, 67% recovered to normal sperm counts within 12 months of cessation, and 90% within 24 months. However, these were generally healthy volunteers on controlled doses — men who have used TRT for years, at high doses, or who had pre-existing impaired spermatogenesis may recover more slowly or incompletely.
Trying to Conceive at Home?
If your partner has recently stopped TRT and sperm parameters are recovering — even at low concentrations — optimizing sperm delivery can make a meaningful difference in your chances of conception.
MakeAMom makes reusable at-home insemination kits in three designs: the CryoBaby for frozen or low-volume sperm, the Impregnator for low-motility sperm, and the BabyMaker for those with sensitivities. All ship discreetly and cost far less than a clinical IUI cycle.
Explore home insemination kits at MakeAMom →
Factors That Predict Slower or Incomplete Recovery
Recovery is less predictable — and may be permanently compromised — in men with:
- Long duration of TRT use (especially >3–5 years)
- High doses (supraphysiological, as seen in anabolic steroid abuse)
- Pre-existing spermatogenic dysfunction (prior azoospermia, genetic causes, severe varicocele)
- Older age at cessation (>45)
- Concurrent use of other anabolic-androgenic steroids (19-nortestosterone compounds like nandrolone are particularly suppressive)
Men with any of these risk factors should be counseled early about fertility preservation — ideally before starting TRT — and should work with a reproductive urologist when stopping.
When Fertility May Be Irreversible
A small but real subset of men does not recover spermatogenesis after stopping TRT. The exact percentage is unknown, but case series and retrospective studies suggest that prolonged, high-dose testosterone use — especially combined with other anabolic steroids — can cause permanent testicular atrophy and irreversible suppression of the germinal epithelium.
Warning signs that recovery may be incomplete:
- Testicular volume <12 mL after 12+ months off TRT
- FSH remains persistently elevated (suggests primary testicular failure)
- Biopsy showing Sertoli cell-only or maturation arrest pattern
In these men, surgical sperm retrieval (micro-TESE or TESE) may be the only path to biological fatherhood. A reproductive urologist should perform testicular histology evaluation before declaring azoospermia permanent.
Clomiphene Citrate: A Fertility-Preserving Alternative to TRT
For men with hypogonadotropic hypogonadism — low testosterone caused by insufficient LH/FSH rather than primary testicular failure — clomiphene citrate (Clomid) is a proven, fertility-preserving alternative to TRT. A complete evaluation including semen analysis is covered in the male fertility testing guide.
Clomiphene works by blocking estrogen receptors in the hypothalamus, which removes the negative feedback signal and causes the pituitary to increase LH and FSH secretion. The result: higher endogenous testosterone production and — critically — maintained or improved spermatogenesis.
Clomiphene vs TRT: Key Differences
| Testosterone Replacement Therapy | Clomiphene Citrate | |
|---|---|---|
| Mechanism | Replaces testosterone externally | Stimulates endogenous production |
| Effect on FSH/LH | Suppresses both to near-zero | Raises both |
| Effect on spermatogenesis | Shuts down | Preserves or improves |
| Testicular volume | Decreases over time | Maintained or increases |
| Testosterone level achieved | High (often supraphysiological) | Moderate (often low-normal to normal) |
| Side effects | Erythrocytosis, azoospermia, testicular atrophy | Mood changes, blurred vision (rare), estrogen elevation |
| Fertility-safe? | No | Yes |
Typical clomiphene doses range from 25–50 mg daily or every other day. Testosterone levels generally rise within 4–8 weeks, and most men feel symptomatic improvement comparable to TRT — without the spermatogenic suppression.
Not all men with low testosterone are candidates for clomiphene. Men with primary hypogonadism (elevated FSH, intrinsic testicular failure) will not respond to clomiphene because the problem is in the testicle, not the pituitary.
HCG Co-Administration: Protecting Fertility While on TRT
For men who are committed to TRT but are concerned about fertility or want to maintain testicular function, human chorionic gonadotropin (HCG) co-administration is an evidence-based option.
HCG mimics LH — it directly stimulates Leydig cells to produce intratesticular testosterone and helps maintain testicular volume and spermatogenesis while exogenous testosterone is suppressing FSH and LH.
The ASRM and Endocrine Society both recognize HCG co-administration as a strategy for men on TRT who wish to preserve fertility. Typical protocols use HCG 500–1000 IU subcutaneously 2–3 times per week alongside TRT.
HCG does not fully replace FSH — which is also important for sperm development — so some degree of spermatogenic suppression may still occur. Men on TRT + HCG should still have serial semen analyses to confirm sperm production is maintained.
For complete spermatogenesis maintenance, some protocols add recombinant FSH alongside HCG and TRT, though this is expensive and generally reserved for men with documented azoospermia on TRT who are not yet ready for assisted reproduction.
FSH and LH Recovery: What Lab Values Tell You
When a man stops TRT, monitoring FSH and LH is crucial for tracking HPG axis recovery.
| Lab Value | Interpretation |
|---|---|
| LH rising toward normal | Pituitary recovering; Leydig cells will resume testosterone production |
| FSH rising toward normal | Sertoli cells receiving signal; spermatogenesis resuming |
| FSH persistently elevated above normal | Primary testicular failure — insufficient Sertoli/Leydig response |
| Both LH and FSH remain suppressed | HPG axis not yet recovered; may need more time or gonadotropin stimulation |
| Testosterone low but FSH/LH elevated | Primary hypogonadism; exogenous gonadotropins may be needed |
Recovery of FSH typically lags behind LH. Sperm appearance in the ejaculate follows FSH recovery by approximately 2–3 months (reflecting the time required for a new spermatogenic cycle to complete).
Practical Guidance for Men on TRT Who Want Children
If You Haven't Started TRT Yet
- Bank sperm first. Sperm cryopreservation before starting TRT is inexpensive ($300–$600) and provides biological insurance. There is no downside and the peace of mind is significant.
- Ask your prescriber about clomiphene. If your low testosterone is secondary (pituitary-driven), clomiphene may raise your testosterone just as effectively without suppressing fertility.
- Discuss timeline. If you plan to try to conceive within 2–3 years, TRT may not be worth the recovery time involved.
If You Are Already on TRT
- See a reproductive urologist. Before stopping TRT, get a baseline semen analysis to understand where you're starting from.
- Stop TRT with medical supervision. Your urologist may prescribe HCG, clomiphene, or FSH injections to accelerate HPG axis recovery.
- Plan for 6–18 months. Set realistic expectations with your partner. Most men begin seeing sperm within 3–6 months; reaching adequate concentrations for natural conception may take 12–18 months.
- Consider IVF/ICSI if needed. If semen parameters do not recover to adequate levels within 18–24 months of cessation, IVF/ICSI with any available sperm — or testicular sperm extraction if azoospermia persists — is a viable path.
Frequently Asked Questions
Q: Does testosterone replacement therapy always cause infertility? A: TRT reliably suppresses sperm production by shutting down the HPG axis — the hormonal signaling chain between the brain and testes. Azoospermia (zero sperm) occurs in 40–65% of men within 4–6 months and in over 90% on long-term high-dose use. It is not a permanent state in most cases, but it is a predictable consequence of TRT that should be discussed before starting treatment.
Q: How long does it take for sperm production to recover after stopping TRT? A: Recovery varies. A meta-analysis by Liu et al. (2006) found that 67% of men recover spermatogenesis within 12 months of stopping TRT and 90% within 24 months. Recovery is slower and less complete after prolonged high-dose use. Most men begin seeing sperm return within 3–6 months; reaching concentrations adequate for natural conception may take 12–18 months.
Q: What is the fertility-preserving alternative to TRT for men with low testosterone? A: For men with secondary (hypogonadotropic) hypogonadism — where low testosterone stems from insufficient signaling from the pituitary — clomiphene citrate stimulates the body's own LH and FSH production, raising testosterone levels while preserving or improving sperm production. It is not appropriate for primary testicular failure, but it is an important fertility-preserving option for the subset of men whose hypogonadism has a central (pituitary) origin.
Q: Can a man stay on TRT and still try to conceive? A: HCG co-administration (500–1000 IU injected 2–3 times per week) can partially preserve spermatogenesis in men who must remain on TRT, because HCG mimics LH and directly stimulates the testes to maintain intratesticular testosterone. However, sperm counts are typically lower than baseline and this approach does not work for all men. Stopping TRT and allowing full recovery is generally more effective when fertility is the primary goal.
Q: Should men bank sperm before starting TRT? A: Yes. Sperm banking before starting TRT is a straightforward biological insurance policy. The process takes one or two clinic visits and costs approximately $300–$600 for the initial banking fee plus annual storage. Because TRT-induced azoospermia is predictable and recovery is not guaranteed in all men, banking sperm beforehand provides a fallback option for IVF or ICSI without requiring natural spermatogenesis recovery.
Key Takeaways
- TRT reliably suppresses sperm production by shutting down the HPG axis; azoospermia occurs in up to 90% of men on long-term TRT
- Recovery after stopping TRT takes 6–24 months; most men recover, but some do not — especially after prolonged high-dose use
- Clomiphene citrate is a fertility-preserving alternative for men with secondary (hypogonadotropic) hypogonadism
- HCG co-administration can partially preserve spermatogenesis in men who must remain on TRT
- Sperm banking before starting TRT should be standard practice for any man who may want children
- If fertility is the priority, TRT is the wrong tool — work with a reproductive urologist and/or endocrinologist before starting
References
- American Society for Reproductive Medicine (ASRM). Testosterone therapy and male infertility: a committee opinion. Fertil Steril. 2020;113(4):715–721.
- Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595–2602.
- Liu PY, Swerdloff RS, Christenson PD, et al. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367(9520):1412–1420.
- World Health Organization. Infertility definitions and terminology. WHO; 2023.
- Crosnoe LE, Grober E, Ohl D, Kim ED. Exogenous testosterone: a preventable cause of male infertility. Transl Androl Urol. 2013;2(2):106–113.
This article is for informational purposes only and does not constitute medical advice. Consult a board-certified reproductive urologist or endocrinologist for guidance specific to your health situation.




